Sanofi
CIK 1121404
13F filing for Q2 2026・No. 3,740
- Holdings
- US$534.04M
- Quarter change
- +US$198.08M
- Entries
- 10
- Net bought (estimate)
- +US$51.3M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 2
- Sold out 1
- Cut 0
- Added 0
- Corporate actions 0
- Unchanged 8
Largest holdings
10 stocks worth US$534.04M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| MeiraGTx Holdings plcCOM | Unchanged | 12,197,737 | US$164.79M | 30.86% |
| Inhibrx Biosciences, Inc.COM | Unchanged | 1,157,926 | US$109.71M | 20.54% |
| NovavaxCOM NEW | Unchanged | 6,880,481 | US$64.81M | 12.14% |
| AnaptysBioCOM | Unchanged | 821,917 | US$55.48M | 10.39% |
| ODTXOdyssey Therapeutics Inc.COMMON STOCK | New | 1,991,918 | US$37.27M | 6.98% |
| Agomab Therapeutics NVSPONSORED ADS | Unchanged | 2,783,096 | US$36.12M | 6.76% |
| MapLight Therapeutics Inc.COM | Unchanged | 912,041 | US$32.69M | 6.12% |
| First Tracks Biotherapeutics Inc.ORD SHS | New | 821,917 | US$16.54M | 3.10% |
| Immuneering CorpCLASS A COM | Unchanged | 2,708,559 | US$13.52M | 2.53% |
| Q32 Bio Inc.COM | Unchanged | 244,083 | US$3.11M | 0.58% |
Sign in (free) to see its 10 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled July 28, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.